Pharmacokinetics and Metabolism of Streptochlorin and Its Synthetic Derivative, 5-Hydroxy-2 '-isobutyl Streptochlorin, in Mice
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhou, Yuanyuan | - |
dc.contributor.author | Choi, Yeon Jung | - |
dc.contributor.author | Kim, Eunyeong | - |
dc.contributor.author | Oh, Mun Hwan | - |
dc.contributor.author | Shin, Hee Jae | - |
dc.contributor.author | Kim, Sang Kyum | - |
dc.contributor.author | Lee, Kiho | - |
dc.date.accessioned | 2021-09-02T14:47:09Z | - |
dc.date.available | 2021-09-02T14:47:09Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-03 | - |
dc.identifier.issn | 0918-6158 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/77268 | - |
dc.description.abstract | The purpose of this study was to investigate the pharmacokinetics and metabolism of streptochlorin and its derivative 5-hydroxy-2'-isobutyl streptochlorin (HIS) in mice. Plasma concentration of streptochlorin declined rapidly resulting in a high sustemic plasma clearance (CLp) (5.8 +/- 1.7L/h/kg), a large volume of distribution (V-ss) (1.4 +/- 0.9L/kg) and a short half-life (t(1/2)) (0.4 +/- 0.1 h) after a single intravenous administration (5mg/kg). Oral bioavailability (F) was 10.3 +/- 3.4% after a single oral administration (10 mg/kg). HIS also showed a rapid plasma decline with a high CLp (11.3 +/- 8.8L/h/kg), a high V-ss (0.8 +/- 1.0L/kg) and a short t(1/2) (0.070 +/- 0.004h) following intravenous administration. It was not detected in plasma after oral administration. Metabolic stability studies using mouse liver microsomes and S9 fractions predicted a high hepatic clearance for both compounds, consistent with the in vivo data. Metabolite identification studies revealed three metabolic pathways for streptochlorin: monooxygenation, glucuronidation of the indole moiety and oxidative opening of the 4-chlorooxazole ring. HIS was metabolized via monooxygenation of the isobutyl chain and glucuronidation of the indole ring. These results may aid in structural optimization to mitigate the metabolic liability of streptochlorin. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PHARMACEUTICAL SOC JAPAN | - |
dc.subject | MARINE NATURAL-PRODUCTS | - |
dc.subject | IN-VITRO METABOLISM | - |
dc.subject | WELL-STIRRED MODEL | - |
dc.subject | DRUG DISCOVERY | - |
dc.subject | ALDEHYDE OXIDASE | - |
dc.subject | RAT | - |
dc.subject | PERMEABILITY | - |
dc.subject | PARAMETERS | - |
dc.subject | CLEARANCE | - |
dc.subject | ANALOGS | - |
dc.title | Pharmacokinetics and Metabolism of Streptochlorin and Its Synthetic Derivative, 5-Hydroxy-2 '-isobutyl Streptochlorin, in Mice | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kiho | - |
dc.identifier.scopusid | 2-s2.0-85047603896 | - |
dc.identifier.wosid | 000426890500007 | - |
dc.identifier.bibliographicCitation | BIOLOGICAL & PHARMACEUTICAL BULLETIN, v.41, no.3, pp.326 - 337 | - |
dc.relation.isPartOf | BIOLOGICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.title | BIOLOGICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.volume | 41 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 326 | - |
dc.citation.endPage | 337 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | MARINE NATURAL-PRODUCTS | - |
dc.subject.keywordPlus | IN-VITRO METABOLISM | - |
dc.subject.keywordPlus | WELL-STIRRED MODEL | - |
dc.subject.keywordPlus | DRUG DISCOVERY | - |
dc.subject.keywordPlus | ALDEHYDE OXIDASE | - |
dc.subject.keywordPlus | RAT | - |
dc.subject.keywordPlus | PERMEABILITY | - |
dc.subject.keywordPlus | PARAMETERS | - |
dc.subject.keywordPlus | CLEARANCE | - |
dc.subject.keywordPlus | ANALOGS | - |
dc.subject.keywordAuthor | streptochlorin | - |
dc.subject.keywordAuthor | 5-hydroxy-2 &apos | - |
dc.subject.keywordAuthor | -isobutyl streptochlorin | - |
dc.subject.keywordAuthor | pharmacokinetics | - |
dc.subject.keywordAuthor | metabolism | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.